Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 12/2009

01-12-2009 | Research Articles

Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study

Authors: Pilar Ma. Samper Ots, Concha López Carrizosa, Aurora Rodríguez, Juan de Dios Sáez, José María Delgado, Manuel Martín de Miguel, Montserrat Vidal

Published in: Clinical and Translational Oncology | Issue 12/2009

Login to get access
Metadata
Title
Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study
Authors
Pilar Ma. Samper Ots
Concha López Carrizosa
Aurora Rodríguez
Juan de Dios Sáez
José María Delgado
Manuel Martín de Miguel
Montserrat Vidal
Publication date
01-12-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0451-6

Other articles of this Issue 12/2009

Clinical and Translational Oncology 12/2009 Go to the issue

Educational Series

Laparoscopic radical cystectomy

Editorial

Clinical practice guidelines for cancer care: what are they for?

Suplementary Information

Lung Cancer OncoGuia: surgical pathology report guidelines

Educational Series

Molecular mechanisms behind the resistance of cisplatin in germ cell tumours

Case Reports

Benefit of sperm freezing before radical orchiectomy

News and Views

About societies and congresses
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits